Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report issued on Saturday. The firm set a “sell” rating on the basic materials company’s stock.

Separately, HC Wainwright restated a “buy” rating and issued a $6.00 price objective on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Arcadia Biosciences Price Performance

RKDA opened at $2.74 on Friday. Arcadia Biosciences has a fifty-two week low of $1.85 and a fifty-two week high of $5.34. The company’s 50-day moving average is $3.34 and its 200 day moving average is $3.06. The firm has a market capitalization of $3.73 million, a P/E ratio of -0.64 and a beta of 1.27.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.